← All trials
NCT03156101
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2017
- Primary completion
- Jun 30, 2020
- Completion date
- Dec 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Shenzhen BinDeBio Ltd.Lead sponsor
- Shenzhen BinDeBio Ltd.Study director
- Zhengzhou UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.